I'm not certain that the current FDA structure could provide that stability.
Orrin Hatch: “I'm not certain that the current FDA structure could provide that stability.”
Editor's note · Context
Hatch expresses doubt about the FDA's ability to ensure stability in healthcare testing.
Share
More from Orrin Hatch
The Congressional Budget Office projects that the PBGC's multiemployer insurance system will exceed resources available to pay claims by $45 billion.
I just can't express my gratitude for the kindness of my dear friend from Pennsylvania. This means so much to me. I didn't even realize it was going to happen. I hustled over here, and there it was. I say to the Senator, I am grateful to…
I rise today to introduce the Traumatic Brain Injury Program Reauthorization Act of 2018. I want to thank my colleague, Senator Casey, for working with me once again on important legislation to reauthorize the Federal Traumatic Brain…





